PMDA
- Application: Spiolto
- Local brand name: Spiolto
- Status: approved
🇯🇵 Placebo Respimat in Japan
Placebo Respimat (Placebo Respimat) regulatory status in Japan.
Marketing authorisation
Other Respiratory approved in Japan
Frequently asked questions
Is Placebo Respimat approved in Japan?
Yes. PMDA has authorised it.
Who is the marketing authorisation holder for Placebo Respimat in Japan?
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.